E8001
/ Eisai
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 25, 2023
A Study to Assess the Safety and Tolerability of E8001 in Healthy Male Participants
(clinicaltrials.gov)
- P1 | N=36 | Completed | Sponsor: Eisai Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion
March 30, 2023
A Study to Assess the Safety and Tolerability of E8001 in Healthy Male Participants
(clinicaltrials.gov)
- P1 | N=36 | Active, not recruiting | Sponsor: Eisai Co., Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed
August 04, 2022
A Study to Assess the Safety and Tolerability of E8001 in Healthy Male Participants
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: Eisai Co., Ltd. | Trial completion date: Sep 2022 ➔ Sep 2023 | Trial primary completion date: Sep 2022 ➔ Sep 2023
Trial completion date • Trial primary completion date
1 to 3
Of
3
Go to page
1